AKT1 and polycystic ovary syndrome: In this study, a total of 174 DEGs and 10 hub genes were identified as new candidate targets for IR in PCOS individuals, and we indicated that the down-regulation of the PI3K/Akt signaling pathway may act as the underlying molecular basis of IR in PCOS, which may provide a new direction for developing novel treatment strategies for PCOS.